The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Tuberculosis, miliary
Publications
Scrofuloderma and Miliary Tuberculosis in a Patient Taking Adalimumab.
Journal of general internal medicine 2023 Sep;38;2832-2833 — 2023 Sep — 2832-2833
Miliary tuberculosis developing during adalimumab treatment for Behçet's disease with uveitis.
BMJ case reports 2018 Dec 04;11; — 2018 Dec 04
Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-? antagonists: implications for management?
The Journal of rheumatology 2012 Jun;39;1297-8 — 2012 Jun — 1297-8